Search research articles
Contact Us
Filters
Showing results (511-520 of 538) with videos related to
Page
of 54
Sort By:
European Journal of Haematology
|
April 21, 2023
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study
Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, et al.
European Journal of Haematology
|
February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT
Laurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
British Journal of Haematology
|
February 15, 2022
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Dawn Swan, Patrick J Hayden, Dirk-Jan Eikema, et al.
Bone Marrow Transplantation
|
May 24, 2020
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Leopold Sellner, Johannes Schetelig, Linda Koster, et al.
Haematologica
|
December 22, 2022
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
Dai Chihara, Luuk Gras, Nienke Zinger, et al.
Cancers
|
July 27, 2024
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study Group
Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, et al.
Bone Marrow Transplantation
|
August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
Bone Marrow Transplantation
|
February 16, 2022
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Joanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, et al.
Bone Marrow Transplantation
|
January 31, 2024
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksac, Diderik-Jan Eikema, Linda Koster, et al.
Transplantation and Cellular Therapy
|
October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Page
of 54
Search research articles
Search
Showing results (511-520 of 538) with videos related to
Sort By:
Page
of 54
European Journal of Haematology
|
April 21, 2023
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study
Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, et al.
European Journal of Haematology
|
February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT
Laurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
British Journal of Haematology
|
February 15, 2022
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Dawn Swan, Patrick J Hayden, Dirk-Jan Eikema, et al.
Bone Marrow Transplantation
|
May 24, 2020
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Leopold Sellner, Johannes Schetelig, Linda Koster, et al.
Haematologica
|
December 22, 2022
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
Dai Chihara, Luuk Gras, Nienke Zinger, et al.
Cancers
|
July 27, 2024
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study Group
Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, et al.
Bone Marrow Transplantation
|
August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
Bone Marrow Transplantation
|
February 16, 2022
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Joanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, et al.
Bone Marrow Transplantation
|
January 31, 2024
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksac, Diderik-Jan Eikema, Linda Koster, et al.
Transplantation and Cellular Therapy
|
October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Page
of 54